Home › Eczema › Indiana › Indianapolis
Eczema clinical trials in Indianapolis, IN
5 studies for Eczema are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
RecruitingPhase 1Healthy volunteers welcome
- Clinical Site 106, Plainfield · 14 mi away
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
About Eczema
Eczema is a general term for different types of rashes. Atopic dermatitis, the most common type, is an allergic skin reaction. Read about treatments.
More about Eczema on MedlinePlus
Eczema trials in other cities
- San Antonio, TX7 studies
- Birmingham, AL6 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- San Diego, CA5 studies
- Miami, FL4 studies
- Santa Clarita, CA4 studies
- Phoenix, AZ4 studies
- Pittsburgh, PA4 studies
- Huntington Beach, CA4 studies
- Washington, DC4 studies
- San Francisco, CA3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.